Daniel Brune
Family · Creve Coeur, ILNPI 1578272431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 443 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,243, more than ten times the $120 reported in 2022. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$950
- Lilly USA, LLC$868
- Boehringer Ingelheim$675
- Abbott$641
- AbbVie$610
- Pfizer$524
- plus $5K from 30 others
What the payments were for
- Food & beverage$9,173100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $950 |
| Lilly USA, LLC | 45 | $868 |
| Boehringer Ingelheim | 33 | $675 |
| Abbott | 18 | $641 |
| AbbVie | 30 | $610 |
| Pfizer | 33 | $524 |
| Novartis | 25 | $463 |
| Otsuka America Pharmaceutical, Inc. | 20 | $444 |
| Bayer | 23 | $431 |
| Novo Nordisk | 18 | $388 |
| Teva Pharmaceuticals USA, Inc. | 21 | $382 |
| Kowa Pharmaceuticals America, Inc. | 19 | $344 |
| Lundbeck LLC | 16 | $299 |
| Idorsia Pharmaceuticals US Inc | 16 | $291 |
| E.r. Squibb & Sons, L.L.C. | 16 | $291 |
| Neurocrine Biosciences, Inc. | 11 | $276 |
| Astellas Pharma US Inc | 10 | $181 |
| Harmony Biosciences LLC | 8 | $179 |
| Merck | 7 | $135 |
| GSK | 6 | $130 |
| Phathom Pharmaceuticals, Inc. | 6 | $122 |
| Amgen | 6 | $96 |
| Almatica Pharma LLC | 4 | $79 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Mylan Specialty L.p. | 1 | $30 |
| Mylan Pharmaceuticals Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Gilead | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$291
- FARXIGA$125
How this compares
$9,177 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $54 |
| Levothyroxine Sodium | 11 | $25 |
| Cyclobenzaprine Hcl | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other family in Creve Coeur
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.